Showing 1 - 10 of 31
Choice is often touted as a means for change within health care systems. Yet 'choice', in this context, takes at least three distinct forms: choice between providers within a publicly funded health care system; choice between competing insurers within a universal plan; and, lastly, choice as...
Persistent link: https://www.econbiz.de/10012764718
Persistent link: https://www.econbiz.de/10009691967
Persistent link: https://www.econbiz.de/10001401327
Persistent link: https://www.econbiz.de/10003862872
Persistent link: https://www.econbiz.de/10001611900
This article presents research demonstrating that the right to health plays different roles in different types of health systems. In high-income countries with tax-funded health systems, we usually encounter a lack of an enforceable right to heath. In contrast, rights play a more significant...
Persistent link: https://www.econbiz.de/10012944654
In this paper, we provide a brief forensic of the SARS crisis in Toronto and analyze the effectiveness of Canada's health care system in response to that crisis. We conclude that it is difficult to draw concrete conclusions about the cause and effect of the SARS epidemic. Nevertheless, there is...
Persistent link: https://www.econbiz.de/10012771553
While political realities make it quite unlikely the United States will move to a single-payer system, there may nevertheless be lessons to be drawn from Canada's experience as well as from the experience of other nations. Canadian Medicare is presented as both a savior and a foe to American...
Persistent link: https://www.econbiz.de/10013049859
Blurring of public/private divide is occurring in different ways around the world, with differential effects in terms of access and equity. In Canada, one pathway towards privatization has received particular attention: duplicative private insurance, allowing those with the financial means to...
Persistent link: https://www.econbiz.de/10013050099
In their efforts to sustain publicly funded health care, governments are increasingly deciding that some drugs are not sufficiently beneficial to merit public funding. For example, the Ontario government has elected not to fund bortezomib. The administration of such cancer drugs requires nursing...
Persistent link: https://www.econbiz.de/10013050102